ABL1 and acute lymphoblastic leukemia: Individual MRD marker establishment leaded to the following results: in the CML-BP and the Ph + BCP-ALL patient BCR-ABL1 (p210 and p190 transcript respectively) analysis via real time PCR including sanger sequencing for mutational analysis were used.